US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022



Generic injectables are widely used in the treatment of various chronic diseases such as cancer, diabetes, cardiovascular diseases, respiratory diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, etc. In the United States, these drugs form an important part of the public healthcare system and contribute in significant savings for the patients and healthcare providers. According to IMARC Group’s new report titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the US generic injectables market reached a value of US$ 10 Billion in 2016, exhibiting a CAGR of more than 9% during 2009-2016. The market growth can be attributed to the low cost of these drugs as compared to their branded counterparts. Moreover, as there is limited price erosion and low competition in the market, the profit margins are significantly higher than commoditised generics.

Over the next few years, the market is expected to be driven by a number of favourable factors. The cases of chronic diseases have been increasing on account of ageing population, sedentary lifestyles and poor eating habits. This has resulted in a heightened demand for generic injectables. Furthermore, the drug shortages in the country coupled with speedy approvals by the USFDA are expected to boost the manufacturing of these drugs. Additionally, the patent expiry of a large number of branded injectable drugs is expected to support the market growth. As a result, the market is projected to reach a value of more than US$ 16 Billion by 2022, growing at a CAGR of around 8% during 2017-2022.

The report has segmented the market on the basis of therapeutic area and covers oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular diseases, etc. Among these, oncology generic injectables represent the largest segment. The report has further analysed the various containers used for generic injectables including vials, premix, prefilled syringes and ampoules. On the basis of distribution channels, the report finds that hospitals dominate the market, accounting for the majority of the share. The report has also examined the competitive landscape of the market and provides the profiles of the key players operative in it. Some the major players are Hospira, Hikma, App, Sagent, Sandoz and Henry Shein, Inc.

This report provides a deep insight into the US generic injectables industry covering all its essential aspects. This ranges from a macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the US generic injectables industry in any manner.

 

Key Questions Answered in This Report:

  • How has the US generic injectables market performed so far and how will it perform in the coming years?
  • What are the price trends of generic injectables in the US?
  • What are the various stages in the value chain of the generic injectables industry?
  • What are the key driving factors and challenges in the US generic injectables industry?
  • What is the structure of the US generic injectables industry and who are the key players?
  • What is the degree of competition in the US generic injectables industry?
  • What are the profit margins in the generic injectables industry?
  • What are the key requirements for setting up a generic injectables manufacturing plant?
  • How are generic injectables manufactured?
  • What are the various unit operations involved in a generic injectables manufacturing plant?
  • What is the total size of land required for setting up a generic injectables manufacturing plant?
  • What are the machinery requirements for setting up a generic injectables manufacturing plant?
  • What are the raw material requirements for setting up a generic injectables manufacturing plant?
  • What are the packaging requirements for generic injectables?
  • What are the transportation requirements for generic injectables?
  • What are the utility requirements for setting up a generic injectables manufacturing plant?
  • What are the manpower requirements for setting up a generic injectables manufacturing plant?
  • What are the infrastructure costs for setting up a generic injectables manufacturing plant?
  • What are the capital costs for setting up a generic injectables manufacturing plant?
  • What are the operating costs for setting up a generic injectables manufacturing plant?
  • What will be the income and expenditures for a generic injectables manufacturing plant?
  • What is the time required to break-even?

1 Preface
2 Scope and Methodology

    2.1     Objectives of the study
    2.2     Stakeholders
    2.3     Data Sources
        2.3.1     Primary Sources
        2.3.2     Secondary Sources
    2.4     Market Estimation
        2.4.1     Bottom-Up Approach
        2.4.2     Top-Down Approach
    2.5     Forecasting Methodology
3 Executive Summary
4 Introduction

    4.1 Overview
    4.2 Key Industry Trends
5 Global Generic Drug Industry
   5.1 Market Overview
   5.2 Market Performance
        5.2.1 Sales Volume 
        5.2.2 Sales Value 
   5.3 Market Breakup by Country 
   5.4 Market Forecast
6 US Generic Drug Industry
   6.1 Market Overview
   6.2 Market Performance
        6.2.1 Sales Volume 
        6.2.2 Sales Value 
   6.3 Market Forecast
7 US Generic Drug Industry – Drug Delivery Systems
   7.1 Orals
   7.2 Injectables
   7.3 Dermal/Topical
   7.4 Inhalers
8 Global Generic Injectables Industry
   8.1 Market Overview
   8.2 Market Performance
   8.3 Market Breakup by Region 
   8.4 Market Breakup by Therapeutic Area
   8.5 Market Breakup by Containers
   8.6 Market Breakup by Distribution Channel
   8.7 Market Share of Key Players
   8.8 Market Forecast
9 US Generic Injectables Industry
    9.1 Market Overview
    9.2 Market Performance
    9.3 Market by Therapeutic Area
    9.4 Market by Containers
    9.5 Market by Distribution Channel
    9.6 Market Share of Key Players
    9.7 Market Forecast
  9.8 SWOT Analysis
       9.8.1 Overview
       9.8.2 Strength
       9.8.3 Weakness
       9.8.4 Opportunity
       9.8.5 Threat
   9.9 Value Chain Analysis
   9.10 Porters Five Forces Analysis
        9.10.1 Overview
        9.10.2 Bargaining Power of Buyers
        9.10.3 Bargaining Power of Suppliers
        9.10.4 Degree of Rivalry
        9.10.5 Threat of New Entrants
        9.10.6 Threat of Substitutes
   9.11    Key Success and Risk Factors
10 Market by Therapeutic Area
    10.1 Oncology
    10.2 Anaesthesia
    10.3 Anti-infectives
    10.4 Parenteral Nutrition
    10.5 Cardiovascular
11 Market by Containers
    11.1 Vials
    11.2 Ampoules
    11.3 Premix
    11.4 Prefilled Syringes
12 Market by Distribution Channel
    12.1 Hospitals
    12.2 Retail Pharmacy 
13 US Generic Injectable Market: Competitive Landscape
    13.1 Competitive Structure
    13.2 Market Breakup by Key Players
14 Generic Injectables Manufacturing Process
     14.1 Product Overview
     14.2 Detailed Process Flow
     14.3 Various Types of Unit Operations Involved
     14.4 Mass Balance and Raw Material Requirements
15 Project Details, Requirements and Costs Involved
     15.1 Land, Location and Site Development
     15.2 Construction Requirements 
     15.3 Machinery Requirements
     15.4 Machinery Pictures
     15.5 Raw Materials Requirements 
     15.6 Raw Material and Final Product Pictures
     15.7 Packaging Requirements 
     15.8 Transportation Requirements 
     15.9 Product Pricing and Margins Across Various Levels of the Supply Chain
16    Key Players Profiles 


List of Figures

Figure 1: Global: Generic Drug Market: Sales Volume Trends (in Billion Standard Units), 2009 – 2016
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2009 – 2016
Figure 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2016
Figure 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2016
Figure 5: Global: Generic Drug Market Forecast: Sales Volume Trends (in Billion Standard Units), 2017 – 2022
Figure 6: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2017 – 2022
Figure 7: US: Generic Drug Market: Sales Volume Trends (in Billion Standard Units), 2009 – 2016
Figure 8: US: Generic Drug Market: Sales Value Trends (in Billion US$), 2009 – 2016
Figure 9: US: Generic Drug Market Forecast: Sales Volume Trends (in Billion Standard Units), 2017 – 2022
Figure 10: US: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2017 – 2022
Figure 11: Global: Generic Drug Market: Drug Delivery System (in %), 2016
Figure 12: Global: Generic Injectables Market: Sales Value Trends (in Billion US$), 2009 – 2016
Figure 13: Global: Generic Injectables Market: Breakup by Region (in %), 2016
Figure 14: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2016
Figure 15: Global: Generic Injectables Market: Breakup by Containers (in %), 2016
Figure 16: Global: Generic Injectables Market: Breakup by Distribution Channels (in %), 2016
Figure 17: Global: Generic Injectables Market: Share of Key Players (in %), 2016
Figure 18: Global: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2017 – 2022
Figure 19: US: Generic Injectables Market: Sales Value Trends (in Billion US$), 2009 – 2016
Figure 20: US: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2016
Figure 21: US: Generic Injectables Market: Breakup by Container (in %), 2016
Figure 22: US: Generic Injectables Market: Breakup by Distribution Channels (in %), 2016
Figure 23: US: Generic Injectables Market: Share of Key Players (in %), 2016
Figure 24: US: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2017 – 2022
Figure 25: US: Generic Injectables Industry: SWOT Analysis
Figure 26: US: Generic Injectables Industry: Value Chain Analysis
Figure 27: US: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 28: US: Oncology: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
Figure 29: US: Anaesthesia: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
Figure 30: US: Anti-infectives: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
Figure 31: US: Parenteral Nutrition: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
Figure 32: US: Cardiovascular: Generic Injectable Market (in Million US$), 2009, 2016 and 2022
Figure 33: US: Vials: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
Figure 34: US: Ampoules: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
Figure 35: US: Premix: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
Figure 36: US: Prefilled Syringes: Generic Injectable Market (in Million US$), 2009, 2016 and 2022
Figure 37: US: Hospitals: Generic Injectable Market (in Million US$), 2009, 2016 & 2022
Figure 38: US: Retail Pharmacy: Generic Injectable Market (in Million US$), 2009, 2016 and 2022
Figure 39: Generic Injectable Manufacturing: Detailed Process Flow
Figure 40: Generic Injectable Manufacturing Process: Conversion Rate of Feedstock
Figure 41: Generic Injectable Manufacturing: Production Cost Breakup (in %)
Figure 42: Generic Injectable Manufacturing: Profit Margins at Various Levels of the Supply Chain 


List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2016 and 2022
Table 2: US: Generic Drug Market: Key Industry Highlights, 2016 and 2022
Table 3: Global: Generic Injectables Market: Key Industry Highlights, 2016 and 2022
Table 4: US: Generic Injectables Market: Key Industry Highlights, 2016 and 2022
Table 5: US: Generic Injectables Market Forecast: Breakup by Therapeutic Area, 2017-2022
Table 6: US: Generic Injectables Market Forecast: Breakup by Containers, 2017-2022
Table 7: US: Generic Injectables Market Forecast: Breakup by Distribution Channel, 2017-2022
Table 8: Generic Injectable Manufacturing Plant: Costs Related to Land and Site Development 
Table 9: Generic Injectable Manufacturing Plant: Costs Related to Civil Works 
Table 10: Generic Injectable Manufacturing Plant: Costs Related to Machinery Unit 
Table 11: Generic Injectable Manufacturing Plant: Raw Material Requirements
 


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Artificial organs are engineered devices that are implanted in a human body in order to replace a natural organ or perform a specific function. They are composed of the plastic that is seeded with stem cells from the transplant recipient, hence the body’s immune system does not reject the artifici...


Biopreservation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

The latest report by IMARC Group, titled “Biopreservation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the market has witnessed a healthy growth over the past few years, reaching a value of about US$ 2.5 Billion in 2016.


GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GCC generic drugs industry in any manner.


Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s latest report titled, “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global generic injectables market reached a value of more than US$ 23 Billion in 2016, exhibiting a CAGR of around 9% during 2009-...


Global Biopharmaceutical Manufacturing Market Report 2017-2021

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2017-2021” provides a detailed analysis on the global biopharmaceutical manufacturing industry. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compar...